Brandon MacIsaac has extensive experience in regulatory submissions and clinical research, currently serving as the Director of Regulatory Submissions Program Management at Juul Labs since September 2018. In this role, Brandon leads FDA submission strategy and manages Pre-Market Tobacco Applications (PMTA), providing regulatory guidance to various cross-functional groups. Prior positions at Juul Labs include Senior Program Manager and Project Manager in Regulatory & Scientific Operations. Brandon's background includes clinical trial management at both Gilead Sciences and Stanford University School of Medicine, focusing on clinical contracts and leading coordination of multi-site clinical studies. An academic foundation in Immunology & Infectious Disease from the University of Alberta further supports Brandon’s expertise in the medical and research sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices